Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I TrialSwetha Kambhampati, Charalambos Andreadis, Joseph M. Tuscano et al.|Clinical Lymphoma Myeloma & Leukemia|2020Cited by 8
A Phase 1b Dose Escalation Trial of Carfilzomib in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin LymphomaSwetha Kambhampati, Charalambos Andreadis, Bita Fakhri et al.|Blood|2019Cited by 0